---
figid: PMC8977174__TCA-13-1027-g006
pmcid: PMC8977174
image_filename: TCA-13-1027-g006.jpg
figure_link: /pmc/articles/PMC8977174/figure/tca14354-fig-0003/
number: FIGURE 3
figure_title: ''
caption: Overexpression of ADAMDEC1 promotes the proliferation of NSCLC cells. (a)
  EDU assay was applied to compare the cell proliferation ability of CTRL, OE‐NC,
  OE‐ ADAMDEC1, shCTRL and shADAMDEC1 groups in HCC827 and NCI‐H1299 cells (scale
  bar, 100 μm); (b) Colony formation capacity of CTRL, OE‐NC, OE‐ ADAMDEC1, shCTRL
  and shADAMDEC1 groups in HCC827 and NCI‐H1299 cells; data represent mean values ± SD
  from three replicates of each sample; **p < 0.01
article_title: Upregulation of ADAMDEC1 correlates with tumor progression and predicts
  poor prognosis in non‐small cell lung cancer (NSCLC) via the PI3K/AKT pathway.
citation: Weiliang Zhu, et al. Thorac Cancer. 2022 Apr;13(7):1027-1039.
year: '2022'

doi: 10.1111/1759-7714.14354
journal_title: Thoracic Cancer
journal_nlm_ta: Thorac Cancer
publisher_name: John Wiley & Sons Australia, Ltd

keywords:
- ADAMDEC1
- apoptosis
- non‐small cell lung cancer
- prognosis
- proliferation

---
